Revolutionary advances in the prevention of demyelinating diseases

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 28, Issue 2, 2009, Pages 143-152

  Edlich, Richard F ^a,b   Mason, Shelley S ^b   Chase, Margot E ^b   Fisher, Allyson L ^b   Gubler, K Dean ^b   Long III, William B ^b   Newkirk, Anthony T ^c  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b LEGACY EMANUEL HOSPITAL   (United States)

^c Synergy Dental   (United States)

Author keywords

Multiple sclerosis; Silver mercury amalgam; Ultraviolet radiation; Vitamin D receptor gene (VDRG); Vitamin D3

Indexed keywords

COLECALCIFEROL; DENTAL ALLOY; VITAMIN D RECEPTOR;

DEMYELINATING DISEASE; DISEASE COURSE; DISEASE EXACERBATION; DNA POLYMORPHISM; HUMAN; LATITUDE; MULTIPLE SCLEROSIS; POPULATION MIGRATION; PRIORITY JOURNAL; REVIEW; TOOTH FILLING; ULTRAVIOLET RADIATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 70350114085     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v28.i2.60     Document Type: Review

References (25)

1. Edlich RF, Pine SA. The quest for the cure of all chronic illnesses: A wake-up call from the President of the United States. J Emerg Med. 2000;19(3):281-285
2. McMichael AJ, Hall AJ. Multiple sclerosis and ultraviolet radiation: time to shed more light. Neuroepidemiology. 2001;20(3):165-167
3. Sawcer S, Robertson N, Compston A. Genetic epidemiology of multiple sclerosis. In: Thompson AJ, Polman C, Hohlfeld R, editors. Multiple sclerosis; clinical challenges and controversies. London: Martin Dunitz; 1997. P. 13-34.
4. Dean G, Elian M. Age at immigration to England of Asian and Caribean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry. 1997;63:565-568
5. Hayes CE, Cantorona MT, DeLuca HF. Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med. 1997;216:21-27
6. Acheson ED, Bachrach CA, Wright FM. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables. Acta Psychiatr Scand. 1960;35: 132-147
7. van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, Butzkueven H, McMichael AJ. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol. 2007;254(5):581-590
8. Freedman DM, Dosemeci M, Alavanja MC. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med. 2000 Jun;57(6):418-421
9. van der Mei IA, Ponsobby AL, Dwyer T, Blizzard L, Simmon R, Taylor NV, Butzkueven, Kilpatrick T. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ. 2003 Aug 9;327(7410):316.
10. Munger KL, Zhang MD, O'Reilly E, Hernan MA, Olek MJ, Willet WC, Ascherio A. Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004 Sep 14;63(5):939; author reply 939.
11. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. J Am Med Assoc. 2006 Dec 20;296(23):2832-2838 (Pubitemid 44969183)
12. Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Hamada T, Miyasaka K, Tashiro K. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J Neurol Sci. 1999;166(1):47-52. (Pubitemid 29327245)
13. Niino M, Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Tashiro K. Vitamin D receptor gene polymorphism in multiple sclerosis and the association with the HLA class II alleles. J Neurol Sci. 2000;177: 65-71.
14. Tajouri L, Ovcaric M, Curtain R, Johnson MP, Griffiths LR, Csurhes P, Pender MP, Lea RA. Variation in the Vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J Nerurogenet. 2005;19:25-38.
15. Hayes CE. Vitamin D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc. 2000;59(4):531-535
16. Steckley JL, Dyment DA, Sadovnick AD, Risch N, Hayes C, Ebers GC. Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients. Canadian Collaborative Study Group. Neurology. 2000 Feb 8;54(3):729-732
17. Yeo TW, Maranian M, Singlehurst S, Gray J, Compston A, Sawcer S. Four single nucleotide polymorphisms from the vitamin D receptor gene in UK multiple sclerosis. J Neurol. 2004 Jun;251(6):753-754
18. Kimball SM, Ursell MR, O'Connor P, Vieth R. Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr. 2007;86(3):645-651
19. Siblerud RL, Kienholz E. Evidence that mercury from silver dental fillings may be an etiological factor in multiple sclerosis. Sci Total Environ. 1994;142(3):191-205.
20. Edlich RF, Greene JA, Cochran AA, Kelley AR, Gubler KD, Olson BM, Hudson MA, Woode DR, Long WB 3rd, McGregor W, Yoder C, Hopkins DB, Saepoff JP. Need for informed consent for dentists who use mercury amalgam restorative material as well as technical considerations in removal of dental amalgam restorations. J Environ Pathol Toxicol Oncol. 2007;26(4):305-322
21. Echeverria D, Aposhian HV, Woods JS, Heyer NJ, Aposhian MM, Bittner AC Jr, Mahurin RK, Cianciola M. Neurobehavioral effects from exposure to dental amalgam Hg(o): new distinctions between recent exposure and Hg body burden. FASEB J. 1998 Aug;12(11):971-980
22. Huggins HA, Levy TE. Cerebrospinal fluid protein changes in multiple sclerosis after dental amalgam removal. Altern Med Rev. 1998;3(4):295-300.
23. Edlich RF, Cross CL, Wack CA, Long WB III, Newkirk AT. The Food and Drug Administration agrees to classify mercury fillings. J Environ Pathol Toxicol Oncol. 2008;27(4):303-305
24. Aminzadeh KK, Etminan M. Dental amalgam and multiple sclerosis: a systematic review and meta-analysis. J Public Health Dent. 2007 Winter;67(1):64-66
25. Edlich RF, Greene JA, Cochran AA, Kelley AR, Gubler KD, Olson BM, Hudson MA, Woode DR, Long WB 3rd, McGregor W, Yoder C, Hopkins DB, Saepoff JP. Need for informed consent for dentists who use mercury amalgam restorative material as well as technical considerations in removal of dental amalgam restorations. J Environ Pathol Toxicol Oncol. 2007;26(4):305-322